|
|
.
See Category: Neoplasms
See Header: Carcinoma in situ of skin of lower limb, including hip
ICD-10 (CM) Code and Descriptor
|
D04.72 |
Carcinoma in situ of skin of left lower limb, including hip
|
D0472 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 45.61%
|
23.47%
|
10.74%
|
5.60%
|
3.83%
|
3.00%
|
2.38%
|
1.51%
|
1.39%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D04.72*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,307
|
1,720
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
649
|
650
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
288
|
288
|
|
17262
|
DSTRJ MAL LES T/A/L 1.1-2.0 |
258
|
272
|
|
17000
|
DESTRUCT PREMALG LESION |
194
|
194
|
|
17313
|
MOHS 1 STAGE T/A/L |
171
|
171
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
168
|
488
|
|
11103
|
TANGNTL BX SKIN EA SEP/ADDL |
111
|
133
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
111
|
111
|
|
17261
|
DSTRJ MAL LES T/A/L .6-1.0CM |
108
|
121
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
107
|
107
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
100
|
100
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
82
|
92
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
62
|
62
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
61
|
62
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
58
|
1,479
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
58
|
58
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
53
|
53
|
|
17314
|
MOHS ADDL STAGE T/A/L |
50
|
53
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
50
|
110
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D04.72 related to the following DRG Codes:
606-607
|
